Which statement best describes the proposed mechanisms of lithium's action?
Choose an answer, then check it.
Clinical Pharmacology · Antipsychotics and Mood Stabilizers
Lithium
On this page 6 sections
In 30 seconds
Lithium is the original, still gold-standard mood stabilizer for bipolar disorder, and it is one of the only psychiatric medications with strong evidence for reducing suicide risk. Its downside is a narrow therapeutic index: the dose that helps and the dose that harms sit close together, so lithium therapy is inseparable from routine blood level monitoring. Because the kidney is lithium's only real exit route, anything that dehydrates the patient or drops sodium can push levels into toxic territory. Long-term use also carries real risks to the kidneys, thyroid, and a developing fetus, so teaching and monitoring never stop once the drug is started.
The college version
What lithium is and why it is used
Lithium carbonate is a simple salt, not a complex organic molecule like most psychiatric drugs, yet it remains a first-line treatment for bipolar disorder — effective against manic episodes and, at lower intensity, useful for depressive episodes and long-term relapse prevention. What sets lithium apart from newer mood stabilizers and antipsychotics is the depth of evidence tying it to reduced rates of suicide and suicide attempts in people with bipolar disorder, an effect not clearly replicated by other agents. This is a major reason clinicians continue to reach for a drug that is, in many ways, harder to manage than newer alternatives.
Proposed mechanisms
Lithium's mechanism of action is not fully settled, and students should learn it as leading hypotheses rather than proven fact. Two proposed pathways dominate current thinking. First, lithium is thought to inhibit inositol monophosphatase, an enzyme in the phosphoinositide signaling pathway; by blunting this pathway, lithium may dampen overactive intracellular signaling implicated in mood episodes. Second, lithium appears to inhibit glycogen synthase kinase-3 (GSK-3), an enzyme involved in cell signaling, neuroprotection, and circadian regulation; modulating GSK-3 activity is proposed to stabilize mood and may underlie some of lithium's neuroprotective effects. Neither mechanism is proven to be the definitive explanation for lithium's clinical effect, and both are best understood as proposed, complementary explanations under active research.
Narrow therapeutic index and monitoring
Lithium's therapeutic window — the gap between an effective level and a toxic one — is unusually narrow compared to most medications. This makes serum lithium level monitoring a non-negotiable part of therapy, not an optional check. Levels are drawn as a trough, meaning the blood sample is taken right before the next scheduled dose, when the concentration in the blood is at its lowest point of the dosing cycle. Drawing a level at any other time gives a misleading number, so timing the draw correctly is a key nursing responsibility. Monitoring is more frequent when therapy starts or doses change, and continues at intervals throughout long-term treatment.
Renal excretion and factors that raise lithium levels
Lithium is not metabolized by the liver in any meaningful way; it is filtered and reabsorbed by the kidneys and excreted essentially unchanged. Critically, the kidney handles lithium much like it handles sodium, reabsorbing both through shared pathways in the proximal tubule. This creates the central teaching point of lithium therapy: anything that depletes sodium or reduces renal blood flow causes the kidney to reabsorb more lithium along with the sodium it is trying to conserve, driving serum lithium levels upward even without any change in dose. Common triggers include dehydration, vomiting and diarrhea, a low-sodium diet, heavy sweating, NSAIDs (which reduce renal perfusion), thiazide diuretics (which promote sodium and volume loss), and ACE inhibitors or ARBs (which alter renal hemodynamics). Any of these can convert a previously stable, safe lithium level into a toxic one within days.
Recognizing toxicity
Early toxicity tends to present with gastrointestinal and mild neurologic symptoms: nausea, vomiting, diarrhea, a fine hand tremor, and mild drowsiness or lack of coordination. These early signs are easy to dismiss as unrelated illness, which is exactly why patient education matters. As levels climb further, toxicity becomes more dangerous and neurologic: coarse tremor, confusion, slurred speech, ataxia (unsteady gait), muscle twitching, and in advanced cases, seizures, significantly altered consciousness, and cardiac rhythm disturbances. Advanced toxicity is a medical emergency. The qualitative pattern to remember is that toxicity moves from mild GI upset and fine tremor toward progressively worsening central nervous system dysfunction.
Long-term effects
Chronic lithium use is associated with several effects requiring ongoing surveillance. The kidneys can develop nephrogenic diabetes insipidus, in which the collecting ducts become less responsive to antidiuretic hormone, causing excessive dilute urination and compensatory thirst; with years of use, chronic structural kidney changes can also develop. The thyroid gland is frequently affected, with lithium impairing hormone synthesis and release, leading to hypothyroidism and sometimes a visibly enlarged thyroid, or goiter. Weight gain and a persistent fine tremor are common side effects that affect adherence. In pregnancy, first-trimester lithium exposure carries an increased risk of Ebstein anomaly, a congenital heart defect affecting the tricuspid valve, making preconception counseling essential for anyone of childbearing potential.
Baseline and ongoing monitoring
Before starting lithium, clinicians establish baseline renal and thyroid function, since both organ systems are directly affected by long-term therapy. These are rechecked periodically throughout treatment, alongside routine serum lithium trough levels, so early drift toward toxicity or organ effects can be caught before it becomes severe.
Patient teaching
Because lithium levels are so sensitive to fluid and sodium status, patient education focuses heavily on consistency. Patients are taught to maintain stable, adequate fluid intake and consistent salt intake day to day — not a low-sodium diet, and not sudden large increases either, since either swing changes lithium handling. They are taught to recognize situations that raise risk: an illness with vomiting or diarrhea, unusually heavy sweating, and starting a new medication (especially an NSAID, diuretic, or ACE inhibitor/ARB) without checking with the prescriber first. Patients should know the early warning signs of toxicity and understand that if these appear, they should hold the next dose and call their prescriber or seek medical attention promptly rather than waiting for symptoms to pass on their own.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine lithium is like a thermostat setting that has to stay in a very tight zone — not too low, not too high — for it to work right and stay safe. That is why people taking it get their blood checked often: it is like checking the thermostat to make sure it has not drifted too far in either direction.
The tricky part is this: your kidneys handle lithium kind of like they handle salt. So if your body loses a lot of water or salt — from being sick with vomiting or diarrhea, sweating a ton, eating way less salty food than usual, or taking certain medicines — your kidneys hang onto lithium more tightly, the same way they hang onto salt when supplies run low. That makes the lithium level in the blood climb, even though nobody changed the dose.
Because of this, the key rule for someone on lithium is: keep your water and salt intake steady, day after day, and tell your doctor right away if you get sick with vomiting or diarrhea, sweat heavily, or start a new medicine. Long-term, lithium can also affect the kidneys and the thyroid gland (a small gland in the neck that helps control energy and metabolism), so those get checked regularly too, sort of like a yearly car inspection to catch small problems before they become big ones.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient calls the clinic reporting a new fine hand tremor, mild nausea, and occasional loose stools since starting a diuretic last week. What should the nurse advise, and why?
Show answer
These are early signs of rising lithium levels, likely triggered by the new diuretic reducing sodium and fluid balance; the nurse should advise the patient to hold the dose, avoid the diuretic, and contact the prescriber or seek care promptly so a level can be checked before symptoms progress.
A patient tells you they've started following a very low-sodium diet "to be healthier" since their last lithium level was drawn. Explain why this could be dangerous and what you would tell them.
Show answer
Cutting sodium intake makes the kidneys reabsorb more lithium along with the sodium they are trying to conserve, which can raise lithium toward toxic levels even without a dose change; the patient should be told to keep salt intake steady and consistent rather than restricting it, and to discuss any diet changes with their prescriber first.
Quick check
3 questions here. Answers stay hidden until you check.
A patient on stable lithium therapy develops a several-day episode of vomiting and diarrhea. What is the most likely effect on their serum lithium level, and why?
Choose an answer, then check it.
Which of the following is a recognized long-term effect of chronic lithium therapy?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.